Distribution of silver nanoparticles in pregnant mice and developing embryos

Nanotoxicology

Volumn 6, Issue 8, 2012, Pages 912-922

  Austin, Carlye A ^a   Umbreit, Thomas H ^b   Brown, Ken M ^a   Barber, David S ^c   Dair, Benita J ^b   Francke Carroll, Sabine ^d   Feswick, April ^c   Saint Louis, Melissa A ^a   Hikawa, Hiroyuki ^a   Siebein, Kerry N ^c   Goering, Peter L ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Distribution; Embryos; in vivo; Mice; Nanoparticles; Silver

Indexed keywords

CITRIC ACID; SILVER NANOPARTICLE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDODERM; ENDOMETRIUM; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; LIVER; LUNG; MORPHOLOGY; MOUSE; NONHUMAN; PARTICLE SIZE; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; ROENTGEN SPECTROSCOPY; SPLEEN; TAIL; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; YOLK SAC; ZETA POTENTIAL;

ANIMALS; EMBRYO, MAMMALIAN; FEMALE; MASS SPECTROMETRY; METAL NANOPARTICLES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; PREGNANCY; SILVER; SPECTROMETRY, X-RAY EMISSION;

ANIMALIA; MUS;

EID: 84869004623     PISSN: 17435390     EISSN: 17435404     Source Type: Journal    
DOI: 10.3109/17435390.2011.626539     Document Type: Article

References (51)

1. Andrews GK, Adamson ED, Gedamu L. 1984. The ontogeny of expression of murine metallothionein: comparison with the alphafetoprotein gene. Dev Biol 103: 294-303.
2. Asharani PV, Wu YL, Gong Z, Valiyaveettil S. 2008. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 19(25): 255102(8 pp).
3. Bar-llan O, Albrecht RM, Fako VE, Furgeson DY. 2009. Toxicity assessments of multi-sized gold and silver nanoparticles in zebrafish embryos. Small 5(16): 1897-1910.
4. Burd A, Kwok CH, Hung SC, Chan HS, Gu H, Lam WK, Huang L. 2007. A comparative study of the cytotoxicity of silver-based dressings in monolayer cell, tissue explant, and animal models. Wound Repair Regen 57: 94-104. (Pubitemid 46146668)
5. Chaloupka K, Yogeshkumar M, Seifalian AM. 2010. Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol 28(11): 580-588.
6. Chu M, Wu Q, Yang H, Yuan R, Hou S, Yang Y, et al. 2010. Transfer of quantum dots from pregnant mice to pups across the placental barrier. Small 6(5): 670-678.
7. Cross JC, Werb Z, Fisher SJ. 1994. Implantation and the placenta: key pieces of the development puzzle. Science 266: 1508-1518.
8. Cutnell J, Johnson K. 1998. Physics. 4 th ed. Canada: John Wiley and Sons, Ltd.
9. Dunton A, Al-Alousi LA, Pratten MK, Beck F. 1986. The giant yolk sac: a model for studying early placental transport. J Anat 145: 189-206. (Pubitemid 16110894)
10. Elchiguerra JL, Burt J, Morones JR, Camacho-Bragado A, Gao X, Lara HH, Yacaman MJ. 2005. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnol 3(6): 4 pp.
11. Hougaard KS, Jackson P, Jensen KA, Sloth JJ, Löschner K, Larsen EH, et al. 2010. Effects of prenatal exposure to surface-coated nanosized titanium dioxide (UV-titan) A study in mice. Part Fibre Toxicol 7(16) [online] Available at: http://www.particleandfibretoxicology. com/content/7/1/16. Accessed on 18 June 2011.
12. Huang Y-F, Sefah K, Bamrungsap S, Chang H-T, Tan W. 2008. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 24: 11860-11865.
13. Ip M, Lui SL, Poon VKM, Lung I, Burd A. 2006. Antimicrobial activities of silver dressings: an in vitro comparison. J Med Microbiol 55: 59-63. (Pubitemid 43031239)
14. Ji JH, Jung JH, Kim SS, Yoon J-U, Park JD, Choi BS, et al. 2008. Twenty-eight-day inhalation toxicity study of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 19(10): 857-871.
15. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40(4): 328-346.
16. Jollie WP. 1990. Development, morphology, and function of the yolk-sac placenta of laboratory rodents. Teratol 41: 361-381. (Pubitemid 20110437)
17. Kertschanska S, Schröder H, Kaufmann P 1997. The ultrastructure of the trophoblastic layer of the degu (Octodon degus) placenta: a re-evaluation of the 'channel problem'. Placenta 18(2-3): 219-225. (Pubitemid 27122759)
18. Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, et al. 2008. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 20(6): 575-583. (Pubitemid 351601408)
19. Kittler S, Greulich C, Diendorf J, Koller M, Epple M. 2010. Toxicity of silver nanoparticles increases during storage because of slow dissolution under release of silver ions. Chem Mater 22(16): 4548-4554.
20. Laban G, Nies LF, Turco RF, Bickham JW, Sepulveda MS. 2010. The effects of silver nanoparticles on fathead minnow (Pimephales promelas) embryos. Ecotoxicol 19: 185-195.
21. Lee PC, Meisel D. 1982. Adsorption and surface-enhanced raman of dyes on silver and gold sols. J Phys Chem 86: 3391-3395.
22. Loeschner K, Hadrup N, Qvortup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8: 18.
23. Longmire M, Choyke PL, Kobayashi H. 2008. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3(5): 703-717.
24. Lubick N. 2008. Nanosilver toxicity: ions, nanoparticles-or both? Environ Sci Technol 42: 8617.
25. Menezes V, Malek A, Keelan JA. 2011. Nanoparticulate drug delivery in pregnancy: placental passage and fetal exposure. Curr Pharm Biotechnol 12: 731-742.
26. Oberdörster G. 2010. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267: 89-105.
27. Park K, Park E-J, Chun IK, Choi K, Lee SH, Yoon J, Lee BC. 2011. Bioavailability and toxicokinetics of citrate-coated silver nanoparticles in rats. Arch Pharm Res 34(1): 153-158.
28. Pratten MK, Lloyd JB. 1997. Uptake of microparticles by rat visceral yolk sac. Placenta 18: 547-552. (Pubitemid 27363977)
29. Roe D, Karandikar B, Bonn-Savage N, Gibbins B, Roullet J-B. 2008. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Antimicrob Chemother 61(4): 869-876. (Pubitemid 351426072)
30. Rossant J, Cross JC. 2001. Placental development: Lessons from mouse mutants. Nature 2: 538-548. (Pubitemid 33674027)
31. Sawosz E, Grodzik M, Zeilinska M, Miemiec T, Olszanska B, Chwalibog A. 2009. Nanoparticles of silver do not affect growth, development and DNA oxidative damage in chicken embryos. Arch Geflügelk 73(5): 208-213.
32. Semmler-Behnke M, Fertsch S, Schmid G, Wenk A, Kreyling WG. 2007. Uptake of 1.4 nmversus 18 nmgold nanoparticles in secondary target organs is size dependent in control and pregnant rats after intratracheal or intravenous application. FromEuroNanoForum2007 Proceedings-Nanotechnology in Industrial Applications. Luxembourg: European Communities; 2007. pp. 102-104. Available at: http://www. euronanoforum2007.de/. Accessed 31 July 2011.
33. Shimizu M, Tainaka H, Oba T, Mizuo K, UMezawa M, Takeda K 2009. Maternal exposure to nanoparticulate titanium dioxide during the prenatal period alters gene expression related to brain development in the mouse. Part Fibre Toxicol 6(20) [online]. Available at: http://www.particleandfibretoxicology.com/content/ 6/1/20. Accessed on 18 June 2011.
34. Sikorska J, Szmidt M, Sawosz E, Niemiec T, Grodzik M, Chwalibog A. 2010. Can silver nanoparticles affect the mineral content, structure and mechanical properties of chicken embryo bones? J Anim Feed Sci 19: 286-291.
35. Sileikaite A, Prosycevas I, Puiso J, Juraitis A, Guobiene A. 2006. Analysis of silver nanoparticles produced by chemical reduction of silver salt solution. Mater Sci-Medzg 12(4): 287-291.
36. Sluiter W, Oomens LWM, Brand A, Van Furth R. 1984 Determination of blood volume in the mouse with 51chromium-labelled erythrocytes. J Immunol Methods 73(1): 221-225. (Pubitemid 14019676)
37. Sun RW-Y, Chen R, Chung NP-Y, Ho C-M, Lin C-LS, Che C-M. 2005. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem Commun 2005: 5059-5061. (Pubitemid 41566432)
38. Sung JH, Ji JH, Park D, Yoon JU, Kim DS, Jeon KS, et al. 2009. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 108(2): 452-461.
39. Takahashi S, Matsuoka O. 1981. Cross placental transfer of 198Aucolloid in near term rats. J Radiat Res 22: 242-249. (Pubitemid 11052408)
40. Takahashi Y, Mizuo K, Shinkai Y, Oshio S, Takeda K. 2010. Prenatal exposure to titanium dioxide nanoparticles increases dopamine levels in the prefrontal cortex and neostriatum of mice. Toxicol Sci 35(5): 749-756.
41. Takeda K, Suzuki K-I, Ishihara A, Kubo-Irie M, Fujimoto R, Tabata M, et al. 2009. Nanoparticles transferred from pregnant mice to their offspring can damage the genital and cranial nerve systems. J Health Sci 55(1): 95-102.
42. Takenaka S, Karg E, Moller W, Roth C, Zeisenis A. 2000. A morphological study on the fate of ultrafine silver particles: Distribution pattern of phagocytized metallic silver in vitro and in vivo. Inhal Toxicol 12(3): 291-299.
43. Takenaka S, Karg E, Roth C, Schultz H, Ziesenis A, Heinzmann U, et al. 2001. Pulmonary and systemic distribution of inhaled ultrafine silver particles in rats. Environ Health Perspect 109(4): 547-551. (Pubitemid 32834568)
44. Tong L, Cobley CM, Chen J, Xia Y, Cheng J-X. 2010. Bright threephoton luminescence from gold/silver alloyed nanostructures for bioimaging with negligible photothermal toxicity. Angew Chem Int Ed 49: 3485-3488.
45. Tsuchiya T, Oguri I, Yamakoshi YN, Miyata N. 1996. Novel harmful effects of [60]fullerene on mouse embryos in vitro and in vivo. FEBS Lett 393: 139-145. (Pubitemid 26298248)
46. Watson ED, Cross JC. 2005. Development of structures and transport functions in the mouse placenta. Physiology 20: 180-193. (Pubitemid 40807056)
47. Wick P, Malek A, Manser P, Meili D, Maeder-Althaus X, Diener L, et al. 2010. Barrier capacity of human placenta for nanosized materials. Environ Health Perspect 118(3): 432-436.
48. Wijnhoven SWP, Peijnenburg WJGM, Herberts CA, Hagens WI, Oomen AG, Heugens EHW, et al. 2009. Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment Nanotoxicol 3: 109-138.
49. Wong KKY, Liu X. 2010. Silver nanoparticles-the real "silver bullet" in clinical medicine? Med Chem Commun 1: 125-131.
50. Woodrow Wilson International Center for Scholars 2009. A nanotechnology consumer products inventory. [Online] Available at http://wwwnanotechprojectorg/ inventories/consumer/analysis-draft/. Accessed on 20 May 2010.
51. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, et al. 2011. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nature Nanotechnology 6: 321-328.